<DOC>
	<DOCNO>NCT00708227</DOCNO>
	<brief_summary>This study help find certain genetic makeup influence person asthma responds salmeterol , one two drug Advair ( R ) .</brief_summary>
	<brief_title>Pharmacogenetics b2-Agonists Asthma .</brief_title>
	<detailed_description>Patients ask take part research study asthma . This clinical research study do see asthmatic 's gene make-up ( DNA make gene ) affect way respond particular asthma medication call salmeterol . Certain gene make people tall short . Certain gene give people brown black hair . Similarly , certain gene may associate way patient respond asthma medication . Salmeterol xinafoate ( long act bronchodilator ) fluticasone propionate ( inhaled corticosteroid ) medicine contain Advair Diskus . During study , patient asthma receive fluticasone inhaler ( call Flovent ) Advair Diskus . The investigator want find patient asthma certain gene respond different way salmeterol Advair Diskus . The investigator also want find patient asthma certain gene treat salmeterol two week airways open less usual use albuterol .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Diplotype : Whites specific diplotype African Americans specific diplotypes . Gender : Male female . Women eligible pregnant lactating . Females subject childbearing potential undergo urine pregnancy test prior methacholine challenge test . Age : 12 year old . Asthma Diagnosis : Physician diagnose asthma accord American Thoracic Society criterion least 3 month . Asthma Therapy : There requirement previous asthma therapy include study . Asthma Severity : forced expiratory volume first sectond ( FEV1 ) must &gt; = 60 % predict normal value age , height , gender . methacholine challenge test provocative concentration ( 20 % fall FEV1 ) [ &lt; =12 ] mg/ml . History lifethreatening asthma : Any episode asthma require intubation associate hypercapnia , respiratory arrest , hypoxic seizure . Asthma instability : Hospitalization asthma within 3 month Visit 1 . Concurrent respiratory disease : Any respiratory disease asthma . Sensitivities : Sensitivities methacholine , Flovent® MDI , ipratropium bromide , albuterol , Advair Diskus® would put safety subject risk . Respiratory Tract Infection : Any sinus , middle ear , oropharyngeal , upper low respiratory tract infection resolve least 2 week immediately precede Visit 1 , antibiotic therapy complete least 2 week prior Visit 1 . Expected exposure pollen allergen patient sensitive ( medical history symptom ) 29 day study period . These patient study pollen exposure sensitive occur .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Pharmacogenetics</keyword>
	<keyword>Salmeterol</keyword>
	<keyword>African American</keyword>
	<keyword>White</keyword>
</DOC>